Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Gilson Biagini"'
Autor:
Paulo C. Gregório, Gilson Biagini, Regiane S. da Cunha, Júlia Budag, Ana Maria Martins, Lara Valiño Rivas, Elberth M. Schiefer, Maria Dolores Sánchez-Niño, Alberto Ortiz, Andréa E. M. Stinghen, Fellype C. Barreto
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-10 (2022)
Background and Aims: Inflammation and endothelial damage play a pivotal role in Fabry disease (FD) manifestations. In daily clinical practice, FD is mainly monitored by traditional biomarkers of target organ injury, such as serum creatinine and prote
Externí odkaz:
https://doaj.org/article/8ff34d0a10fe41c88d672644d3fe72b9
Autor:
Cristina Techy Roth-Stefanski, Naiane Rodrigues de Almeida, Gilson Biagini, Natália K. Scatone, Fabiana B. Nerbass, Thyago Proença de Moraes
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Objective: To analyze the concordance and agreement between bioimpedance spectroscopy (BIS) and anthropometry for the diagnosis of protein energy wasting (PEW) in chronic peritoneal dialysis patients.Methods: Prospective, multi-center, observational
Externí odkaz:
https://doaj.org/article/e9f47bd47dee4d38906027b22c9bf2d1
Autor:
Gilson Biagini, Ana Clara Simões Flórido Almeida, Tammy Vernalha Rocha Almeida, Cassiano Augusto Braga Silva, Bruna Fernanda de Castro, Tais Cristina Reche, Ana Cláudia Dabinski, Fellype Carvalho Barreto
Publikováno v:
Brazilian Journal of Nephrology, Vol 39, Iss 3, Pp 333-336
Abstract Fabry disease is an X-linked lysosomal storage disease due to alpha-galactosidase A (α-Gal A) deficient activity which leads to the accumulation of glucoesphingolipids, such as globotriaosilceramide. There are over 700 known mutations of th
Externí odkaz:
https://doaj.org/article/854702f13e724f1e9c6104d9016837c2
Autor:
Paulo C. Gregório, Gilson Biagini, Regiane S. da Cunha, Júlia Budag, Ana Maria Martins, Lara Valiño Rivas, Elberth M. Schiefer, Maria Dolores Sánchez-Niño, Alberto Ortiz, Andréa E.M. Stinghen, Fellype Carvalho Barreto
Publikováno v:
Kidney & Blood Pressure Research (2022)
Background and aims: Inflammation and endothelial damage play a pivotal role in Fabry disease (FD) manifestations. In daily clinical practice, FD are mainly monitored by traditional biomarkers of target organ injury, such as serum creatinine and prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::92203a3c7fff00bbb6626820e70dd560
https://www.karger.com/Article/FullText/521329
https://www.karger.com/Article/FullText/521329
Autor:
Ana Carolina Buffara BLITZKOW, Gilson BIAGINI, Carlos Antonio SABBAG, Victor Assad BUFFARA-JUNIOR
Publikováno v:
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), Volume: 35, Article number: e1690, Published: 16 SEP 2022
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.35 2022
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Colégio Brasileiro de Cirurgia Digestiva (CBCD)
instacron:CBCD
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) v.35 2022
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
Colégio Brasileiro de Cirurgia Digestiva (CBCD)
instacron:CBCD
BACKGROUND: The success of peritoneal dialysis depends on the proper placement and functional longevity of the dialysis catheter. Laparoscopic implantation of a catheter through a rectus sheath tunneling can minimize the risks of catheter failure. AI
Autor:
Andréa E.M. Stinghen, Fellype C. Barreto, Gilson Biagini, Bruna Bosquetti, Maria Dolores Sanchez-Niño, Paulo Gregório, Regiane Stafim da Cunha, Julia Budag, Alberto Ortiz
Publikováno v:
Nephrology Dialysis Transplantation
Background and Aims COVID-19 is a pandemic with no end in sight. There is only one approved antiviral agent but global stocks are deemed insufficient. Despite in vitro antiviral activity, clinical trials of chloroquine and hydroxychloroquine were dis
Autor:
Ana Maria Martins, Andressa Flores, Maria Dolores Sanchez-Niño, Alberto Ortiz, Fellype C. Barreto, Paulo Gregório, Regiane Stafim da Cunha, Andréa E.M. Stinghen, Bruna Bosquetti, Gilson Biagini
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Fellype C. Barreto, Julia Budag, Maria Dolores Sanchez-Niño, Alberto Ortiz, Regiane Stafim da Cunha, Gilson Biagini, PauloC. Gregório, Bruna Bosquetti, Andréa E.M. Stinghen
Publikováno v:
Toxicology and Applied Pharmacology
COVID-19 is a pandemic with no end in sight. There is only one approved antiviral agent but global stocks are deemed insufficient. Despite in vitro antiviral activity, clinical trials of chloroquine and hydroxychloroquine were disappointing, and they
Autor:
Hugo Abensur, Ana Maria Martins, Ricardo Villela Bastos, Osvaldo J. M. Nascimento, Sandra Obikawa Kyosen, Paulo Sergio dos Santos Montoril, Jaelson Guilhem Gomes, Dino Martini Filho, Gilson Biagini, Maria Cristina Jacometti Maldonado, Luiz Roberto Carvalho, Vânia D'Almeida, José Sobral Neto, Luiz Octávio Dias D'Almeida, Humberto Cenci Guimarães, Ângela Maria Barbosa Ferreira Gonçalves, Maria Beatriz B.P. Harouche, Edna Tiemi Takata, Alvimar G. Delgado, Caio César Benetti Filho, Helena Pimentel
Publikováno v:
The Journal of Pediatrics. 155:S19-S31
Ana Maria Martins, MD, PhD, Vânia D’Almeida, MD, Sandra Obikawa Kyosen, MD, Edna Tiemi Takata, MD, Alvimar Goncalves Delgado, MD, PhD, Ângela Maria Barbosa Ferreira Goncalves, MD, Caio Cesar Benetti Filho, MD, Dino Martini Filho, MD, Gilson Biagi
Autor:
Gilson Biagini, Fellype C. Barreto, Roberto Pecoits-Filho, Daniela V. Barreto, Tammy V. R. Almeida, Lidio Rossi, Mariza F.G. Rosa
Publikováno v:
Nephrology Dialysis Transplantation. 31:i364-i365